GLASS TUBE FOR PHARMACEUTICAL CONTAINER AND MANUFACTURING PROCESS FOR GLASS TUBE
To solve the problem of condensates from glass compositions during the manufacturing of glass tubes for pharmaceutical containers.SOLUTION: In a glass tube for pharmaceutical containers, a.) the ratio of transmittance for at least one wavelength and/or over the entire wavelength range in the range o...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WITZMANN ANDRE STEPHAN TRATZKY VOLKER TRINKS |
| description | To solve the problem of condensates from glass compositions during the manufacturing of glass tubes for pharmaceutical containers.SOLUTION: In a glass tube for pharmaceutical containers, a.) the ratio of transmittance for at least one wavelength and/or over the entire wavelength range in the range of 350 to 800 nm is at least 0.97, and it has b.) a hydrolytic resistance characterized by an alkali leachability of less than 0.9 μgcm-2, less than 0.7 μgcm-2, or less than 0.5 μgcm-2, determined as relative concentration in an eluate prepared according to ISO 4802-2:2010.SELECTED DRAWING: Figure 1
【課題】医薬品容器用ガラス管を製造する間の、ガラス組成物に由来する凝縮物の問題を解消する。【解決手段】医薬品容器用ガラス管であって、ａ．）３５０～８００ｎｍの範囲における少なくとも１つの波長についての、および／または前記波長範囲全体にわたる透過率の比率は、少なくとも０．９７であり、且つｂ．）ＩＳＯ４８０２－２：２０１０に準拠して調製される溶出液中での相対濃度として特定される０．９μｇｃｍ-2未満、０．７μｇｃｍ-2未満、または０．５μｇｃｍ-2未満のアルカリ浸出性によって特徴付けられる耐加水分解性を有する。【選択図】図１ |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2023080052A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2023080052A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2023080052A3</originalsourceid><addsrcrecordid>eNrjZAhw93EMDlYICXVyVXDzD1II8HAM8nV0dg0N8XR29FFw9vcLcfT0cw1ScPRzUfB19At1c3QOCQ3y9HNXCAjyd3YF6gVpQ5jCw8CalphTnMoLpbkZlNxcQ5w9dFML8uNTiwsSk1PzUkvivQKMDIyMDSwMDEyNHI2JUgQAyuQvZQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>GLASS TUBE FOR PHARMACEUTICAL CONTAINER AND MANUFACTURING PROCESS FOR GLASS TUBE</title><source>esp@cenet</source><creator>WITZMANN ANDRE ; STEPHAN TRATZKY ; VOLKER TRINKS</creator><creatorcontrib>WITZMANN ANDRE ; STEPHAN TRATZKY ; VOLKER TRINKS</creatorcontrib><description>To solve the problem of condensates from glass compositions during the manufacturing of glass tubes for pharmaceutical containers.SOLUTION: In a glass tube for pharmaceutical containers, a.) the ratio of transmittance for at least one wavelength and/or over the entire wavelength range in the range of 350 to 800 nm is at least 0.97, and it has b.) a hydrolytic resistance characterized by an alkali leachability of less than 0.9 μgcm-2, less than 0.7 μgcm-2, or less than 0.5 μgcm-2, determined as relative concentration in an eluate prepared according to ISO 4802-2:2010.SELECTED DRAWING: Figure 1
【課題】医薬品容器用ガラス管を製造する間の、ガラス組成物に由来する凝縮物の問題を解消する。【解決手段】医薬品容器用ガラス管であって、ａ．）３５０～８００ｎｍの範囲における少なくとも１つの波長についての、および／または前記波長範囲全体にわたる透過率の比率は、少なくとも０．９７であり、且つｂ．）ＩＳＯ４８０２－２：２０１０に準拠して調製される溶出液中での相対濃度として特定される０．９μｇｃｍ-2未満、０．７μｇｃｍ-2未満、または０．５μｇｃｍ-2未満のアルカリ浸出性によって特徴付けられる耐加水分解性を有する。【選択図】図１</description><language>eng ; jpn</language><subject>BABY COMFORTERS ; CHEMICAL COMPOSITION OF GLASSES, GLAZES, OR VITREOUSENAMELS ; CHEMISTRY ; CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICALPURPOSES ; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY ; DEVICES FOR RECEIVING SPITTLE ; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGINGPHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL ORADMINISTERING FORMS ; GLASS ; HUMAN NECESSITIES ; HYGIENE ; JOINING GLASS TO GLASS OR OTHER MATERIALS ; MANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MINERAL OR SLAG WOOL ; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS,MINERALS OR SLAGS ; SURFACE TREATMENT OF GLASS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230608&DB=EPODOC&CC=JP&NR=2023080052A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230608&DB=EPODOC&CC=JP&NR=2023080052A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WITZMANN ANDRE</creatorcontrib><creatorcontrib>STEPHAN TRATZKY</creatorcontrib><creatorcontrib>VOLKER TRINKS</creatorcontrib><title>GLASS TUBE FOR PHARMACEUTICAL CONTAINER AND MANUFACTURING PROCESS FOR GLASS TUBE</title><description>To solve the problem of condensates from glass compositions during the manufacturing of glass tubes for pharmaceutical containers.SOLUTION: In a glass tube for pharmaceutical containers, a.) the ratio of transmittance for at least one wavelength and/or over the entire wavelength range in the range of 350 to 800 nm is at least 0.97, and it has b.) a hydrolytic resistance characterized by an alkali leachability of less than 0.9 μgcm-2, less than 0.7 μgcm-2, or less than 0.5 μgcm-2, determined as relative concentration in an eluate prepared according to ISO 4802-2:2010.SELECTED DRAWING: Figure 1
【課題】医薬品容器用ガラス管を製造する間の、ガラス組成物に由来する凝縮物の問題を解消する。【解決手段】医薬品容器用ガラス管であって、ａ．）３５０～８００ｎｍの範囲における少なくとも１つの波長についての、および／または前記波長範囲全体にわたる透過率の比率は、少なくとも０．９７であり、且つｂ．）ＩＳＯ４８０２－２：２０１０に準拠して調製される溶出液中での相対濃度として特定される０．９μｇｃｍ-2未満、０．７μｇｃｍ-2未満、または０．５μｇｃｍ-2未満のアルカリ浸出性によって特徴付けられる耐加水分解性を有する。【選択図】図１</description><subject>BABY COMFORTERS</subject><subject>CHEMICAL COMPOSITION OF GLASSES, GLAZES, OR VITREOUSENAMELS</subject><subject>CHEMISTRY</subject><subject>CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICALPURPOSES</subject><subject>DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY</subject><subject>DEVICES FOR RECEIVING SPITTLE</subject><subject>DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGINGPHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL ORADMINISTERING FORMS</subject><subject>GLASS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>JOINING GLASS TO GLASS OR OTHER MATERIALS</subject><subject>MANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MINERAL OR SLAG WOOL</subject><subject>SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS,MINERALS OR SLAGS</subject><subject>SURFACE TREATMENT OF GLASS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAhw93EMDlYICXVyVXDzD1II8HAM8nV0dg0N8XR29FFw9vcLcfT0cw1ScPRzUfB19At1c3QOCQ3y9HNXCAjyd3YF6gVpQ5jCw8CalphTnMoLpbkZlNxcQ5w9dFML8uNTiwsSk1PzUkvivQKMDIyMDSwMDEyNHI2JUgQAyuQvZQ</recordid><startdate>20230608</startdate><enddate>20230608</enddate><creator>WITZMANN ANDRE</creator><creator>STEPHAN TRATZKY</creator><creator>VOLKER TRINKS</creator><scope>EVB</scope></search><sort><creationdate>20230608</creationdate><title>GLASS TUBE FOR PHARMACEUTICAL CONTAINER AND MANUFACTURING PROCESS FOR GLASS TUBE</title><author>WITZMANN ANDRE ; STEPHAN TRATZKY ; VOLKER TRINKS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2023080052A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; jpn</language><creationdate>2023</creationdate><topic>BABY COMFORTERS</topic><topic>CHEMICAL COMPOSITION OF GLASSES, GLAZES, OR VITREOUSENAMELS</topic><topic>CHEMISTRY</topic><topic>CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICALPURPOSES</topic><topic>DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY</topic><topic>DEVICES FOR RECEIVING SPITTLE</topic><topic>DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGINGPHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL ORADMINISTERING FORMS</topic><topic>GLASS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>JOINING GLASS TO GLASS OR OTHER MATERIALS</topic><topic>MANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MINERAL OR SLAG WOOL</topic><topic>SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS,MINERALS OR SLAGS</topic><topic>SURFACE TREATMENT OF GLASS</topic><toplevel>online_resources</toplevel><creatorcontrib>WITZMANN ANDRE</creatorcontrib><creatorcontrib>STEPHAN TRATZKY</creatorcontrib><creatorcontrib>VOLKER TRINKS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WITZMANN ANDRE</au><au>STEPHAN TRATZKY</au><au>VOLKER TRINKS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>GLASS TUBE FOR PHARMACEUTICAL CONTAINER AND MANUFACTURING PROCESS FOR GLASS TUBE</title><date>2023-06-08</date><risdate>2023</risdate><abstract>To solve the problem of condensates from glass compositions during the manufacturing of glass tubes for pharmaceutical containers.SOLUTION: In a glass tube for pharmaceutical containers, a.) the ratio of transmittance for at least one wavelength and/or over the entire wavelength range in the range of 350 to 800 nm is at least 0.97, and it has b.) a hydrolytic resistance characterized by an alkali leachability of less than 0.9 μgcm-2, less than 0.7 μgcm-2, or less than 0.5 μgcm-2, determined as relative concentration in an eluate prepared according to ISO 4802-2:2010.SELECTED DRAWING: Figure 1
【課題】医薬品容器用ガラス管を製造する間の、ガラス組成物に由来する凝縮物の問題を解消する。【解決手段】医薬品容器用ガラス管であって、ａ．）３５０～８００ｎｍの範囲における少なくとも１つの波長についての、および／または前記波長範囲全体にわたる透過率の比率は、少なくとも０．９７であり、且つｂ．）ＩＳＯ４８０２－２：２０１０に準拠して調製される溶出液中での相対濃度として特定される０．９μｇｃｍ-2未満、０．７μｇｃｍ-2未満、または０．５μｇｃｍ-2未満のアルカリ浸出性によって特徴付けられる耐加水分解性を有する。【選択図】図１</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; jpn |
| recordid | cdi_epo_espacenet_JP2023080052A |
| source | esp@cenet |
| subjects | BABY COMFORTERS CHEMICAL COMPOSITION OF GLASSES, GLAZES, OR VITREOUSENAMELS CHEMISTRY CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICALPURPOSES DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY DEVICES FOR RECEIVING SPITTLE DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGINGPHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL ORADMINISTERING FORMS GLASS HUMAN NECESSITIES HYGIENE JOINING GLASS TO GLASS OR OTHER MATERIALS MANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES MEDICAL OR VETERINARY SCIENCE METALLURGY MINERAL OR SLAG WOOL SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS,MINERALS OR SLAGS SURFACE TREATMENT OF GLASS |
| title | GLASS TUBE FOR PHARMACEUTICAL CONTAINER AND MANUFACTURING PROCESS FOR GLASS TUBE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T23%3A59%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WITZMANN%20ANDRE&rft.date=2023-06-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2023080052A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |